Jamal Rana MD FACC/LinkedIn
Nov 11, 2025, 23:38
The Wall Street Journal Features Major AHA Trials on Cholesterol Breakthroughs
Jamal Rana, Professor in the Department of Clinical Science at Kaiser Permanente Bernard J. Tyson School of Medicine, posted on LinkedIn:
”Many reached out requesting access to read the full article. The story made it to the print version, given this was The Wall Street Journal’s main coverage of the biggest trials presented at AHA Scientific Sessions 2025. We are now in era where multiple options exist to aggressively treat LDL cholesterol in high-risk patients to prevent heart disease.
Link here.”
Stay updated with Hemostasis Today.
AHA
American College of Cardiology
American Heart Association
Atherosclerosis
Betsy McKay
Cardiology
Cholesterol
European Atherosclerosis Society
Health
Heart Disease
Heart Health
Hematology
Hemostasis
Hemostasis Today
Jamal Rana
Kaiser Permanente Bernard J. Tyson School of Medicine
Medicine
The Wall Street Journal
thrombosis
-
Apr 8, 2026, 18:14Simon Fletcher: See The Unique Challenges PwH Face During Their Gene Therapy Journey
-
Apr 8, 2026, 17:56Hisam Siddiqi: Understanding Bone Marrow Trephine Morphology in MPNs
-
Apr 8, 2026, 17:46Mohamed Reda: Why Some Veins Decide to Take a ‘Detour’?
-
Apr 8, 2026, 17:39Managing Acquired Von Willebrand Syndrome in a Swine Polytrauma Model During ECLS – JTH
-
Apr 8, 2026, 17:04Heghine Khachatryan: Marfan vs LDS – Not All Aortopathies Are the Same
-
Apr 8, 2026, 17:00Frits Rosendaal Receives ISTH Grant Medal for Lifetime Contributions to Thrombosis and Hemostasis Field
-
Apr 8, 2026, 16:25Xiaoying Chen: Teleneurological Ward As A Practical Way to Support High-Quality Stroke Care Beyond Major Centres
-
Apr 8, 2026, 16:24Ney Carter Borges: Endocrine Drivers of Resistant Hypertension – Insights from the MOMENTUM Trial at ACC 26
-
Apr 8, 2026, 16:21Jonathan Gelber: Exploring Papaya Extract as an Option to Elevate Platelet Numbers Before PRP